Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Sales | 9,621 | 7,396 | 10,252 | 7,091 | 5,011 |
| Gross Profit | 9,621 | 7,396 | 10,252 | 7,091 | 5,011 |
| Operating Expenses | 52,365 | 45,349 | 39,249 | 33,505 | 29,533 |
| Operating Income | -42,744 | -37,953 | -28,997 | -26,414 | -24,522 |
| Other Income | 211 | 295 | 39 | 171 | 318 |
| Pre-tax Income | -42,533 | -37,658 | -28,958 | -26,243 | -24,204 |
| Income Tax | N/A | 44 | -123 | 139 | 71 |
| Net Income Continuous | -42,533 | -37,702 | -28,835 | -26,382 | -24,275 |
| Net Income | $-42,533 | $-37,702 | $-28,835 | $-26,382 | $-24,275 |
| EPS Basic Total Ops | -0.95 | -0.85 | -0.65 | -0.60 | -0.63 |
| EPS Basic Continuous Ops | -0.95 | -0.85 | -0.65 | -0.60 | -0.63 |
| EPS Diluted Total Ops | -0.95 | -0.85 | -0.65 | -0.60 | -0.63 |
| EPS Diluted Continuous Ops | -0.95 | -0.85 | -0.65 | -0.60 | -0.63 |
| EBITDA(a) | $-39,949 | $-35,737 | $-26,855 | $-24,591 | $-22,915 |